ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% – Tale of the Tape

ACADIA Pharmaceuticals Inc. (ACAD) was a big mover last session, as the company saw its shares rise by over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained almost 32% since Feb 5.

This biotechnology company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ACADIA Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Some stocks in the basic materials sector looking equally good include Alexion Pharmaceuticals, Inc. (ALXN), Biogen Idec Inc. (BIIB) and Emergent BioSolutions, Inc. (EBS). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>